Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Endocrinology

This eJournal series consists of expert commentary and key highlights from the Editorial Board of the CME publication series, Dialogues in Diabetes, available in conjunction with Endocrine Today, in September, October, November, and December 2013. Click...
Recent advances with novel orally administered SGLT2 cotransporter inhibitors offers a unique opportunity to address current unmet therapeutic needs and improve outcomes for the patient with T2DM. Optimal use of this new class of agents will require that...
This free CME series is intended for endocrinologists, primary care physicians, nurse practitioners, physician assistants and other healthcare professionals involved in the treatment of patients with Type 2 Diabetes Mellitus (T2DM). Click here to...